AbbVie: Biopharma known for immunology and oncology drugs such as Humira and Skyrizi.
Price
269.37
24H
—
Volume 24h
—
Market Cap
$468.18B
| Venues | Issuers | Symbol | Mark | Volume 24h | Liquidity | Vol % | Contract |
|---|---|---|---|---|---|---|---|
 Gate |  | ABBVX_USDT | 261.90 | — | — | — | Xswbin…Qoie |
 Ondo Markets |  | ABBV | 269.37 | — | — | — | 0x7c73…a504 |
 Solana | | Xswbin…SSQoie | 266.03 | — | $2.61 | — | Xswbin…Qoie |
News
4ABBVAbbVie reaffirms Q3 and full-year EPS guidance
20dABBV▲ABBV listed on WEEX
21dABBV002653▲Haisco's innovative drug HSK51155 tablet obtains clinical trial approval, previously licensed to AbbVie for over $700 million in total
2026-08-18ABBV▲AbbVie beats Q2 EPS estimates on strong Skyrizi and Rinvoq sales
2026-07-31